ABSTRACT Aniridia is a congenital pan-ocular disorder caused by haplo-insufficiency of Pax6, a crucial gene for proper development of the eye. Aniridia affects a range of eye structures, including the cornea, iris, anterior chamber angle, lens, and fovea. The ocular surface in particular can be severely affected by a progressive pathology termed aniridiaassociated keratopathy (AAK), markedly contributing to impaired vision. The purpose of this review is to provide an update of the current knowledge of the genetic, clinical, micromorphological, and molecular aspects of AAK. We draw upon material presented in the literature and from our own observations in large aniridia cohorts. We summarize signs and symptoms of AAK, describe current options for management, and discuss the latest research 2 findings that may lead to better diagnosis and new treatment or prevention strategies for this debilitating ocular surface condition.
regulated downstream genes are essential for cell differentiation. Expression of cytokeratin 12 (K12) is regarded as a marker for corneal-type epithelial differentiation, and it has been shown that PAX6 expression is essential to the upward regulation of the K12 gene in human corneal epithelial cells. 8 Deficiency of K12 makes the corneal epithelium fragile and vacuolated.
A study comparing Sey and wild type mice has revealed peripheral lesions in the Pax6 +/-corneal epithelium. 8 The barrier between conjunctival epithelium and the corneal epithelium was disrupted. Pax6 +/-related opacity formations (both in the epithelium and in the stroma) increased in severity with age, which indicates that the opacities arose from both a degenerative process and a failure of corneal differentiation. 8 The corneal epithelial cells from adult mice have demonstrated abnormal morphology of the nuclei, mitochondria, and cytoskeleton. 7, 19, 20 PAX6 also regulates the expression of cell adhesion molecules. Davis et al have shown large gaps between corneal epithelial cells and an unusual appearance of the desmosomes in Sey mice. 21 These results suggest that desmosomes and the intermediate filaments to which they are attached are abnormal and contribute to the loss of adhesion in the Pax6 +/-mutant cornea.
B. Oxidative Stress, Wound Healing, and Corneal Transparency
In aniridia, corneal epithelial cells are sensitive to oxidative stress, resulting in increased apoptosis and abnormal wound healing. The defective healing is observed both in mice models and clinically, and is related to abnormalities in the cell surface glycoconjugate and deficient and delayed extracellular matrix metabolism. 1, 7, 10, 20, 22, 23 The volume of oxidized proteins increases with age in normal corneas but is more One example of the malfunction of keratocytes/fibroblasts/myofibroblasts is their failure to complete the wound healing response, which can lead to the formation of keloid deposits ( Figure 1 ). 26 The collagenous extracellular matrix of the corneal stroma can also be disrupted in other ways. In MMP-9 deficiency, there is an accumulation of fibrin and premature infiltration of inflammatory cells into the stroma. 27 MMP-9 belongs to an enzyme group known as matrix metalloproteinases, which are regulated by PAX6. In combination with accumulation of pathologic material, the normal collagen-matrix relationship is disturbed, leading to impaired corneal transparency. 8, 10 In experiments with Pax6 +/-mice, several insights have been gained into impaired corneal wound healing. 16, 20 One important finding was that increased stromal apoptosis occurred after wounding, and it has been suggested that apoptosis, as well as deficient and delayed extracellular matrix metabolism, aggravated the corneal changes. 16 A summary of the corneal wound healing and stromal response in AAK is given in Table 1 .
IV. Clinical Signs and the Stages of Aniridia-Associated Keratopathy
It is generally believed that AAK starts in the corneal periphery with conjunctival tissue overriding the limbal barrier and growing onto the peripheral cornea. A fibrovascular pannus forms and is opaque with the presence of blood vessels and inflammatory cells. The pannus eventually grows over the corneal surface, so that the border between the conjunctiva and the corneal epithelium is found in the peripheral or mid-peripheral cornea. In a later stage, this pannus then extends to cover the whole surface and the stroma is affected, which gives rise to a decreasing visual acuity.
The stages of progression of AAK can be classified according to a numeric scale;however, several scales have been suggested and consensus would be advantageous. In Tables 2 and 3 and Figure 2 , examples of previously published clinical grading scales for AAK are given. Despite the differing scales, a threshold between effect on the central cornea (and thereby visual acuity) and non-vision threatening peripheral pathology should ideally be specified.
V. The Limbal Stem Cells and the Stem Cell Niche
The corneal limbal stem cells are located between the palisades of Vogt, tightly attached to the basement membrane. The PAX6 genetic defect influences the regulation of the stem cells, leading to a breakdown of normal function of the limbal barrier and causing conjunctiva to invade the corneal surface. 20, 31 The limbus area acts as a junctional barrier to separate the cornea and conjunctiva, and there is no evidence that conjunctival epithelial cells can transdifferentiate into corneal epithelial cells that express K12. 8 Several studies have shown that stem cell plasticity and pluripotency is determined by environmental factors. In mouse models of aniridia, cell proliferation is not reduced, but it is dysfunctional due to an alteration in the stem cell niche. 7, 8 The presence of conjunctival epithelial cells in the cornea may not only be due to an invasion of the conjunctiva.
Differentiation of progenitor cells into conjunctival and goblet cells in situ in the cornea may occur in an altered corneal microenvironment. The limbal epithelium has been shown to be intermediate between cornea and conjunctiva. 8, 20 Until recently, however, information about the stem cell niche in aniridia has been limited to the heterozygous Pax6 +/-mouse models. 8 The recent advancement of in vivo imaging of the cornea by in vivo confocal microscopy of the cornea (IVCM) has enabled a detailed analysis of the limbal stem cell niche in humans.
For example, it has been shown that in cases of burn-induced limbal stem cell deficiency (LSCD), the presence of the limbal palisades of Vogt (POV) after limbal stem cell transplantation indicates success of the graft, while absence of the POV indicates failure. 32 Moreover, IVCM has shown that loss of the POV correlates with loss of central and limbal basal epithelial cells and an increase in limbal dendritic cells. 32 The corneal or conjunctival epithelial transition zone and cellular phenotype as revealed by IVCM have also been shown in correlation with the presence or absence of the POV in LSCD. 33, 34 In another series of LSCD patients, IVCM was used to examine the POV and limbal epithelium in early, intermediate, and late clinical stages of LSCD, where one could see that the POV were completely degraded at the early stage. 35 The above studies examined LSCD as a heterogeneous group, often with only one or two aniridia patients included. We recently found in a Norwegian cohort of 20 patients with congenital aniridia that the morphology of the POV strongly correlated with stage of aniridiarelated keratopathy. 36 This strong structure-function relationship of the POV in aniridia revealed that a progressive morphologic degradation of the POV correlates with the loss of limbal and corneal epithelial phenotype. In grade 0 of keratopathy, POV were present with a normal morphological appearance, but in grade 1 almost half of the eyes had partially degraded POV, while in the remaining eyes the POV were absent. In all higher grades, no POV were present, while dendritic cell density was significantly increased.
IVCM could be a useful tool in the discovery of early degradative changes in the limbal palisades of Vogt that lead to progressive conjunctivalization of the ocular surface. Future studies should focus on longitudinal monitoring of the POV and associated morphology in patients, to clarify the processes of degradation of the limbal stem cell niche and offer potential insights for future treatment.
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VI. Corneal Nerves
It appears that corneal nerves are directly or indirectly involved in the regulation of the corneal epithelial stem cells. It is known that corneal nerves release trophic factors to maintain a healthy corneal epithelium and epithelial turnover including limbal epithelial cell maintenance. 38, 39 Nerve growth factor and its receptor Trk-A have been implicated as potential markers for human corneal epithelial stem cells. 38, 40 In mouse models, heterozygous Pax6 +/-adult mice exhibited decreased epithelial innervation and nerve patterns were disrupted. 41 In humans, IVCM has been used to quantify subbasal epithelial nerves in LSCD, where a markedly reduced nerve density has likewise been found in a case series without aniridia patients 35 and in a series including two aniridia patients. 34 In a Swedish cohort of 16 aniridia subjects where IVCM was used, a wide range of subbasal nerve density was reported, including 3 patients with abnormally high innervation of the central cornea. 29 Nerve patterns were disrupted, and esthesiometry indicated that corneal touch sensitivity was reduced below normal levels in 5 of 14 patients. It was postulated that an apparent high subbasal nerve density could reflect better visibility of these nerves in vivo, due to thinning of the corneal epithelium in aniridia.
In a more recent report describing in vivo corneal nerves in a larger Norwegian cohort of 20 aniridia patients, both limbal and central corneal subbasal nerves were examined.8 significant correlation was found between limbal epithelial nerve density and grade of keratopathy, while in contrast to the earlier Swedish cohort (where only early-stage keratopathy was examined), the central subbasal nerve density in this larger cohort correlated with grade of keratopathy. 36 It is important to note, however, that a reduced presence of corneal subbasal nerves, while linked to the status of the keratopathy, is not specific to aniridia. Indeed, reduced subbasal nerve density has been reported in numerous conditions, such as dry eye disease, diabetes, keratoconus, and after refractive surgery and corneal transplantation (for a review of confocal imaging of corneal nerves in disease, see reference 42).
A decrease in corneal nerves in aniridia was observed as one of multiple pathologic signs in the development of keratopathy with concomitant invasion of inflammatory cells, degradation of limbal POV, opacification of the anterior stroma, and loss of basal epithelial cells. 29, 36 While each of these features in isolation is not necessarily specific to aniridia, their combination appears to mirror the progression of AAK.
VII. Central Corneal Epithelium
Until now the morphology of the central corneal epithelium in AAK has been poorly understood. Although clinical examination by slit lamp microscopy has been used to grade the progression of keratopathy based on peripheral or central corneal involvement, the slit lamp is limited to macroscopic observation. In our Norwegian aniridia cohort, in vivo confocal microscopic imaging showed microscopic-level morphologic changes in the limbal epithelium. 36 The central cornea, however, exhibits abnormal morphology in aniridia, even in the earliest stages of keratopathy where the central cornea appears clinically normal and transparent. The results of the morphologic findings of central corneal epithelial status are presented in Figure 3 , and have not been previously reported.
In particular, early changes to the epithelial wing and basal cell layers are apparent in stage 0 of AAK and progress through to stage 4. Discrete focal opacities appear in the wing cell layers and increase in size as AAK progresses. Wing cell size also appears to increase, as cell borders become less distinct. In the basal epithelium, inflammatory cells infiltrate and increase in density, with goblet cells and vessels invading in the late stages.
Based on animal models of aniridia 8 and particularly our clinical findings with in vivo confocal microscopy, 28, 35 we hypothesize that limbal epithelial stem cells are present early in 
VIII. Corneal Thickness
The corneal thickness in aniridia patients is usually increased. Brandt et al 9 and
Whitson et al 11 have reported an increased central corneal thickness, which highlights the importance of correcting measured values of intraocular pressure for the actual corneal thickness. The corneal thickness can be measured with, for example, ultrasonic pachymetry and anterior segment optical coherence tomography (OCT). Central corneal thickness has been reported to vary from 632 ± 51 µm (17 patients, 9 ) to 692 ± 75 µm (10 patients, 11 ), compared to a control group where the thickness was 548 ± 21 µm. 11 Likewise, in Swedish and Norwegian cohorts, reported median central corneal thickness was 642 µm (11 patients 29 ) and 623 µm (18 patients 36 ), respectively. Although the origins of the increased stromal thickness in aniridia are unknown, elevated numbers of stromal keratocytes or collagen overproduction have been postulated as possible causes.
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VIII. The Tear Film
Tear fluid has an important function in the maintenance of the ocular surface, supplying nutrients, proteins, and wound-healing modulating factors that are essential for healthy conjunctival and corneal epithelium. [43] [44] [45] [46] [47] Disturbances in secretion or composition of tear film lead to dysfunction of tear film that displays a broad spectrum of symptoms with varying degree of severity associated with many eye pathologies. [48] [49] [50] The most common is dry eye disease, which can be caused either by deficient tear production or increased tear evaporation.
Methods for clinically assessing tear production and function include the Schirmer test, fluorescein-based assessment of TFBUT, and fluorescein and Rose Bengal staining. 51 In aniridia, the TFBUT is often reduced, suggesting tear dysfunction in the majority of patients. 12, 29, 52 The extent of tear instability and meibomian gland dysfunction often correlate with the severity of ocular surface disease 12 and are not associated with dry eye syndrome per se. 52, 53 Another important factor is tear film osmolarity, which is one of the principal indicators of tear function and the condition of ocular surface. 54, 55 Increased tear osmolarity is a significant stress factor that activates several stress-signaling pathways resulting in transcription of stress-related genes, such as proinflammatory cytokines TNF-α, IL-1, IL-6, or matrix metalloproteinases. 46, 47 So far, the osmolarity of aniridic tears has not been assessed and the composition of tear fluid, as well as the expression levels of the particular tear components in aniridia has been largely unknown. Recent research, 53 however, revealed different levels of several proteins in aniridic tears when compared with healthy tears. In particular, the levels of α-enolase, peroxiredoxin 6, cystatin S, gelsolin, and apolipoprotein A-1 were decreased in the tears of aniridia patients, and these proteins, along with the increased levels of 80 kDa isoform of vascular endothelial growth factor that corresponds to VEGF-C, may be involved in the pathogenesis of AAK. AAK is associated with the ingrowth of blood vessels into the cornea that compromise visual acuity. The increased tear levels of VEGF in aniridic tears suggest a breakdown of the balance between pro-and anti-angiogenic factors leading to pathological hem-and lymphangiogenesis and the manifestation of AAK. Increased oxidative stress present in AAK may lead to a greater extent of apoptosis in the corneal epithelium and abnormal corneal wound healing. 16 In these processes, peroxiredoxin 6, VEGF, gelsolin, apolipoprotein A-1, and zinc-α2 glycoprotein may play a substantial role. One study found elevated levels of dinucleotides Ap4A and Ap5A in aniridic tears. 52 The increased levels of dinucleotides could be related to LSCD as a compensatory mechanism to stimulate the proliferation and differentiation of these cells that are deficient in aniridic eyes.
The anterior lipid layer of tear film contains a large array of nonpolar and polar lipids secreted by the meibomian gland. 56, 57 The main function of this layer is to retard tear evaporation from the ocular surface. 56 As mentioned, in aniridic eyes the TFBUT is often short, 29, 52 suggesting disturbances in aniridic tear lipidome and the elevated levels of zinc-α2 glycoprotein, 53 a protein known to stimulate lipid degradation, may play a substantial role in modifying the qualities of the tear lipid layer in aniridia.
The molecular mechanisms on the ocular surface involved in the pathogenesis of aniridia and AAK are presented in Figure 4 .
IX. Treatment of Aniridia-Associated Keratopathy
Therapeutic management of AAK in aniridia depends on the degree of involvement of the ocular surface. As a general recommendation, treatment should be as minimally invasive as possible to avoid accelerating the progression of AAK. 58 Moreover, any type of aesthetic surgery to substitute the iris should be avoided.
For patients with well-preserved corneal transparency (stage 0 of AAK), artificial tears without preservatives containing sodium hyaluronate can be used to treat corneal irritation.
Hyaluronate-containing artificial tears can effectively improve the ocular surface, as demonstrated in patients with dry eye.
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In patients with slight-to-moderate keratopathy, autologous serum eye drops can be used to relieve symptoms from the ocular surface and to improve the surface quality. Recently, a promising treatment approach using postnatal manipulation of PAX6 dosage in a mouse model has been reported. 73 This finding gives hope for the future applicability of gene therapy treatment in early aniridia to reverse major PAX6-related congenital eye defects.
X. Summary and Conclusions
Optimal Table 2 . Classification of aniridia-associated keratopathy (AAK)
Adapted from reference 28.
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